Technology

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal imbalances, resulting in irregular weight patterns. Wisp’s new weight care...

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely. This innovation is targeted...

Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient

Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...

AI Firm Formation Bags $372 Series D Funding

In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...

Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort

California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part...

Musk’s Neuralink Aiming to Enroll Three Patients in Brain Implant Research

According to the information on the clinical trials database maintained by the U.S. government, Neuralink, the brain-chip firm owned by Elon Musk, intends to...

Triomics to attempt to revolutionize clinical trials for cancer patients

Founded by two college friends, Hrituraj Singh and Sarim Khan, Triomics is an artificial intelligence company centered around oncology that has generated buzz in...

Microscopic “super bots” repair neural wound model

In a recent development, scientists have brought science fiction to life by creating miniature biological robots, known as biobots, capable of healing...

Latest news

AstraZeneca’s Obesity Pill Shows Positive Results in Early Trial

AstraZeneca announced that its new weight-loss medication, which was licensed from Eccogene of China, underwent early-stage testing and was...

Novo scores license to use Ascendis’ TransCon platform for $285 million

In exchange for $285 million, Copenhagen-based Ascendis has agreed to help Novo Nordisk develop a once-a-month GLP-1 receptor antagonist...

Apellis and Novartis both target rare kidney diseases with new drugs

Apellis Pharmaceuticals and Novartis recently shared data for their rare kidney disease drugs, pegcetacoplan and iptacopan. Both have performed...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

You might also likeRELATED
Recommended to you

AstraZeneca Acquires Amolyt Pharma, Expanding into Rare Endocrinology

AstraZeneca has made a strategic move into the realm...